Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Related Citations for PubMed (Select 11215743)

1.

Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study.

Furusyo N, Hayashi J, Kanamoto-Tanaka Y, Ariyama I, Etoh Y, Shigematsu M, Kashiwagi S.

Dig Dis Sci. 2000 Nov;45(11):2221-8.

PMID:
11215743
2.

Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.

Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G.

Am J Kidney Dis. 2000 Jan;35(1):122-9.

PMID:
10620553
3.

Spectrum of liver damage and correlation with clinical and laboratory parameters in HCV infected hemodialysis patients.

Sezer S, Ozdemir BH, Arat Z, Turan M, Ozdemir NF, Haberal M.

Ren Fail. 2001 Nov;23(6):807-18.

PMID:
11777320
4.

Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.

Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR.

J Clin Virol. 2006 Mar;35(3):298-302. Epub 2005 Nov 11.

PMID:
16290052
5.

High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.

Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P.

Clin Nephrol. 2000 Aug;54(2):151-6.

PMID:
10968693
6.

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.

J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5.

PMID:
19200132
7.

Natural history of acute HCV infection in hemodialysis patients.

Espinosa M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Rodriguez M, Aljama P.

Clin Nephrol. 2002 Aug;58(2):143-50.

PMID:
12227687
8.

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.

McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ.

J Gastroenterol Hepatol. 2000 Aug;15(8):945-51.

PMID:
11022838
10.

Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.

Kojima H, Hongo Y, Harada H, Inoue T, Miyaji K, Kashiwagi M, Momose T, Arisaka Y, Fukui H, Murai S, Tokita H, Kamitsukasa H, Yagura M, Katsu K.

J Gastroenterol Hepatol. 2001 Sep;16(9):1015-21.

PMID:
11595066
11.

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection.

Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ.

J Viral Hepat. 1998 May;5(3):187-92.

PMID:
9658372
12.

A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia.

Hayashi J, Furusyo N, Ariyama I, Sawayama Y, Etoh Y, Kashiwagi S.

J Infect Dis. 2000 May;181(5):1523-7. Epub 2000 May 15.

13.
14.

Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.

Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.

J Viral Hepat. 2008 Sep;15(9):666-74. doi: 10.1111/j.1365-2893.2008.00992.x. Epub 2008 May 14.

PMID:
18482283
15.

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.

Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.

Am J Gastroenterol. 2000 Apr;95(4):1036-40.

PMID:
10763956
16.

Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.

Dohmen K, Shigematsu H, Irie K, Ishibashi H.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2022-7.

PMID:
14696457
17.

Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.

Himoto T, Hosomi N, Nakai S, Deguchi A, Kinekawa F, Matsuki M, Yachida M, Masaki T, Kurokochi K, Watanabe S, Senda S, Kuriyama S.

Scand J Gastroenterol. 2007 Sep;42(9):1078-87.

PMID:
17710674
18.

Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.

Kato A, Odamaki M, Nakamura H, Yodoi J, Hishida A.

Kidney Int. 2003 Jun;63(6):2262-8.

PMID:
12753316
19.

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis.

Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R.

J Hepatol. 2000 Mar;32(3):447-52.

PMID:
10735615
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk